Lakewood-Amedex Biotherapeutics Inc. (LABT) stock
LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$0.24+0.03 (+11.89%)
Close on Nov 18, 2026Market cap $568.73KP/E –Yield –
Lakewood-Amedex Biotherapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Lakewood-Amedex Biotherapeutics's shares outstanding was 2M at Sep 30, 2026.
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 2M | +243.6% |
| Q2 FY2026 | Jun 30, 2026 | 1M | -79.6% |
| Q1 FY2026 | Mar 31, 2026 | 7M | – |
| Q3 FY2025 | Sep 30, 2025 | 1M | – |
| Q2 FY2025 | Jun 30, 2025 | 1M | – |
| Q1 FY2025 | Mar 31, 2025 | 7M | – |
See a number that looks wrong?